Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition
9 May 2026 – 14 May 2026 · Cape Town, South Africa
669-01-009 ISMRM Abstract

Fuse Cortical Morphometrics and 3D MRI Radiomics to Predict Disability and cognitive Progression in RRMS: A Multicenter study

Primary: Neuro - Multiple Sclerosis
Secondary: Neuro - Neuroinflammation
669-01-009 · Neuroinflammation: Metabolites, Function, and AI · Thursday, 14 May, 8:30 AM–9:25 AM · Digital Posters Row J
Accepted
Zhuo Wang1, Jing Zhang 2, Kai AI3
1Department of Magnetic Resonance, The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, China
2The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, China
3Department of Clinical and Technical Support, Philips Healthcare (Xi'an), Xi'an, China
Presenting Author: Jing Zhang

Synopsis

Motivation:
Goals:
Approach:
Results:
Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

Log in

References

1. Mostardeiro TR, Schmitt LG, de Campos FTX, Xi Y, Brondani Torri G, Carvalho BM, Feltrin FS (2025) Multiple sclerosis lesion detection with 3D double inversion recovery (DIR) as compared to 3D fluid low attenuation inversion recovery (T2-FLAIR): A systematic review and meta-analysis. Mult Scler Relat Disord 93106186.
2. Luo X, Li H, Xia W, Quan C, ZhangBao J, Tan H, Wang N, Bao Y, Geng D, Li Y, Yang L (2024) Joint radiomics and spatial distribution model for MRI-based discrimination of multiple sclerosis, neuromyelitis optica spectrum disorder, and myelin-oligodendrocyte-glycoprotein-IgG-associated disorder. Eur Radiol 34(7):4364-4375.
3. Luo X, Piao S, Li H, Li Y, Xia W, Bao Y, Liu X, Geng D, Wu H, Yang L (2022) Multi-lesion radiomics model for discrimination of relapsing-remitting multiple sclerosis and neuropsychiatric systemic lupus erythematosus. Eur Radiol 32(8):5700-5710.
4. Kalincik T, Cutter G, Spelman T, Jokubaitis V, Havrdova E, Horakova D, Trojano M, Izquierdo G, Girard M, Duquette P, Prat A, Lugaresi A, Grand'Maison F, Grammond P, Hupperts R, Oreja-Guevara C, Boz C, Pucci E, Bergamaschi R, Lechner-Scott J, Alroughani R, Van Pesch V, Iuliano G, Fernandez-Bolaños R, Ramo C, Terzi M, Slee M, Spitaleri D, Verheul F, Cristiano E, Sánchez-Menoyo JL, Fiol M, Gray O, Cabrera-Gomez JA, Barnett M, Butzkueven H (2015) Defining reliable disability outcomes in multiple sclerosis. Brain 138(Pt 11):3287-3298.
5. Benedict RH, DeLuca J, Phillips G, LaRocca N, Hudson LD, Rudick R (2017) Validity of the Symbol Digit Modalities Test as a cognition performance outcome measure for multiple sclerosis. Mult Scler 23(5):721-733.

Cite this abstract

http://echo.ismrm.org/p/ISMRM2026/669-01-009